Prof. Waldhäusl

Ausgewählte Veröffentlichungen - Selected Publications

1964 – 2011

  • (6) K e n n e r, Th. und Waldhäusl, W.: On a non dialysable, heat stabile hypertensive substance in the serum of rats. Nature 214, 581 (1964).
  • (16) P e t e r l i k, M. and Waldhäusl, W.: Isolation of a non dialysable active pressor principle from pig serum. Nature 244: 279 (1967).
  • (43) W a l d h ä u s l, W., C.P.Lucas, J.W.Conn, H.J.Lutz und E.L.Cohen: Studies on the isolation of human renin. Biochem.Biophys.Acta 221: 536-548 (1970).
  • (53) W a l d h ä u s l, W.: Stimulation of immunoreactive insulin and human growth hormone by administration of arginine in patients with proliferative diabetic retinopathy. Acta endocrin. (Kbh.) 70: 719 - (1972)
  • (105) W a l d h ä u s l, W., G.Kleinberger, A.Korn, R.Dudczak, P.Bratusch-Marrain and P.Nowotny: Severe hyperglycemia: Effects of rehydration on endocrine derangements and blood glucose concentrations. Diabetes 28: 577 - 584 (1979).
  • (120) W a l d h ä u s l, W., P.Bratusch-Marrain, S.Gasic, A.Korn and P.Nowotny: Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man. Diabetologia 17: 221 - 228 (1979).
  • (162) V i e r h a p p e r, H., B.Grubeck-Loebenstein, P.Bratusch-Marrain, S.Panzer and Waldhäusl, W.: The impact of euglycemia and hyperglycemia on stimulated pituitary hormone release in insulin in dependent diabetics. J.Clin.Endocrinol.Metab. 52: 1230 - 1234 (1981).
  • (167) W a l d h ä u s l, W., G.Kastner, M.Komjati and P.Bratusch-Marrain: Studies on biological actions of biosynthetic human insulin in vitro and in diabetic man. Diabetes Care 4: 205 - 208 (1981).
  • (168) W a l d h ä u s l, W., P.Bratusch-Marrain, M.Francesconi, P.Nowotny and P.Kiss: Insulin production rate in normal man as an estimate for calibration of continuous intravenous insulin infusion in insulin dependent diabetics. Diabetes Care 5: 18 - 24 (1981).
  • (184) W a l d h ä u s l, W., P.Bratusch-Marrain, S.Gasic, A.Korn and P.Nowotny: Insulin production rate and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic non insulin dependent diabetes mellitus. Diabetologia 23: 6 - 15 (1982).
  • (195) W a l d h ä u s l, W., S.Gasic, P.Bratusch-Marrain, A.Korn and P.Nowotny: Feedback inhibition by biosynthetic human insulin of insulin release in healthy human subjects. Amer.J.Physiol. 243: E476 - E482 (1982).
  • (198) W a l d h ä u s l, W., P.R.Bratusch-Marrain, H.Vierhapper and P.Nowotny: Insulin pharmacokinetics following infusion and bolus injection of regular porcine and human insulin in healthy man. Metabolism 32: 478 - 486 (1983).
  • (208) W a l d h ä u s l, W., S.Gasic, P.Bratusch-Marrain and P.Nowotny: The 75 g oral glucose tolerance test: Effects on splanchnic metabolism of substrates and pancreatic hormone release in healthy man. Diabetologia 25: 489 - 495 (1983).
  • (253) W a l d h ä u s l, W., P. Bratusch-Marrain, V.Kruse, I.Jensen, P.Nowotny and H.Vierhapper: Effect of insulin antibodies on insulin pharmacokinetics and glucose utilization in insulin dependent diabetic patients. Diabetes 34: 166 - 173 (1985).
  • (260) B r a t u s c h - M a r r a i n, P. and W.Waldhäusl: Suppression of basal, but not of glucose-stimulated insulin secretion by human insulin in healthy and obese hyperinsulinaemic subjects. Metabolism 34: 188-193 (1985)
  • (280) K o m j a t i, M., P. Bratusch-Marrain and W.Waldhäusl: Superior efficacy of pulsatile versus continuous hormone exposure on hepatic glucose production in vitro. Endocrinology 118: 312 - 319 (1986).
  • (281) W a l d h ä u s l, W., P.Bratusch-Marrain, S.Gasic, M.Komjati, and Lise Heding: Inhibition by Proinsulin of Endogenous C-Peptide Release in Healthy Man. Amer.J.Physiol. 251: E139 - E145 (1986).
  • (283) W a l d h ä u s l , W.: The physiological basis of insulin treatment - clinical aspects. Diabetologia 29: 837 - 849 (1986).
  • (293) B r a t u s c h - M a r r a i n, P. , M.Komjati, and W.K.Waldhäusl: Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in insulin-dependent diabetic man. Diabetes 35: 922 - 926 (1986).
  • (299) W a l d h ä u s l, W., S.Gasic, P.Bratusch-Marrain, M.Komjati, and Adrienne Korn: Effect of stress hormones on splanchnic substrate and insulin disposal following glucose ingestion in healthy man. Diabetes 36: 127 - 135 (1987).
  • (360) R a t h e i s e r ,K., W.Reitgruber, M.Komjati, P.Bratusch-Marrain, H.Vierhapper and W.Waldhäusl: Quantitative and qualitative differences in basal and glucose- and arginine-stimulated insulin secretion in healthy subjects and different stages of NIDDM. Acta diabetol.latina 27: 197 - 213 (1990).
  • (371) W a l d h ä u s l ,W.: Rational treatment of NIDDM. Does it exist? Diabetes, Nutrition, Metabolism Reviews 4: 259 - 265 (1990).
  • (374) R a t h e i s e r, K., M.Komjati, S.Gasic, P.Bratusch-Marrain, and W.Waldhäusl: Effect of stress hormones on transsplanchnic balance of exogenous amino acids in healthy man. Metabolism 40: 1298 - 1304 (1990).
  • (377) F a s c h i n g, P., K.Ratheiser, W.Waldhäusl, Madeleine Rohac, W.Osterrode, P.Nowotny, and H.Vierhapper: Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance. Diabetes 40: 583 - 589 (1991).
  • (379) F ü r n s i n n, C., M.Komjati, O.D.Madsen, B.Schneider and W. Waldhäusl: Lifelong sequential changes in glucose tolerance and insulin secretion in genetically obese Zucker rats (fa/fa) fed a diabetogenic diet. Endocrinology 128: 1093 - 1099 (1991).
  • (393) R o d e n, M., K.Liener, C.Fürnsinn, U.Hollenstein, H.Vierhapper, and W.Waldhäusl: Effects of amyloid polypeptide on hepatic insulin resistance and glucose production in the isolated perfused rat liver. Diabetologia 35: 116 - 120 (1992).
  • (403) W a l d h ä u s l, W., P.Bratusch-Marrain, M.Komjati, F.Breitenecker, and I.Troch: Blood glucose response to stress hormone exposure in healthy man and insulin dependent diabetic patients: Prediction by computer modelling. IEEE Transactions on Biomed. Engineering 39: 779 - 790 (1992).
  • (413) F a s c h i n g, P., K.Ratheiser, D.Damjancic, B.Schneider, P.Nowotny, H.Vierhapper and W.Waldhäusl: Acute and chronic near-normoglycaemia are required to improve insulin resistance in insulin-dependent (Type 1) diabetes. Diabetologia 36: 346 - 351 (1993).
  • (418) R o d e n, M., K.Liener, C.Fürnsinn, M.Prskavec, P.Nowotny, Ilse Steffan, H.Vierhapper, and W. Waldhäusl: Non-insulin like action of sodium orthovanadate in the isolated perfused liver of fed non-diabetic rats. Diabetologia 36: 602 - 607 (1993).
  • (428) F a s c h i n g, P., K.Derfler, Th.Maca, S.Kurzemann, K.Howorka, B.Schneider, M.Zirm and W.Waldhäusl: Feasibility and efficacy of intensive insulin therapy in Type 1 diabetes mellitus in primary care. Diabetic Medicine 11: 836 - 842 (1994).
  • (436) F a s c h i n g, P., K.Ratheiser, P.Nowotny, S.Kurzemann, S.Parzer, and W.Waldhäusl: Insulin production following i.v.glucose, arginine and valine: Different pattern in patients with impaired glucose tolerance and in NIDDM. Metabolism 43: 385 - 389 (1994).
  • (440) K r e i n e r, G., M.Woltzt, P.Fasching, T.Leitha, A.Edlmayer, A.Korn, W.Waldhäusl, and R.Dudczak: Myocardial I-123 Meta-Iodobenzylguanidine Scintigraphy for the Assessment of Adrenergic Cardiac Innervation in Patients with Insulin Dependent Diabetes Mellitus-Comparison with Cardiovascular Reflex Tests and Relationship to Left Ventricular Function. Diabetes 44: 543 - 549 (1995).
  • (441) R o d e n, M., M.Prskavec, C.Fürnsinn, I.Elmadfa, J.König, B.Schneider; O.Wagner, and W.Waldhäusl: Effects of sodium selenite on glucose production in the isolated perfused rat liver. Hepatology 22: 169 - 174 (1995).
  • (443) Baumgartner-Parzer, S.M., L.Wagner, M.Pettermann, A.Gessl and W.Waldhäusl: High glucose of adhesion molecule expression in cultured endothelial cells. Diabetologia 38: 1367 - 1370 (1995).
  • (448) Baumgartner-Parzer, S.M., L.Wagner, M.Pettermann, J.Grillari, A.Gessl and W.Waldhäusl: High glucose triggered apoptosis in cultured endothelial cells. Diabetes 44: 1323 - 1327 (1995).
  • (480) Fürnsinn, C., S.Neschen, C.Noe, M.Bisschop, M.Roden, C.Vogl, B.Schneider and W.Waldhäusl: Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro. Brit.J.Pharmacol. 122: 1367 – 1374 (1997).
  • (505) Roden, M., M.Krssak, H.Stingl, St.Gruber, A.Hofer, C.Fürnsinn, E.Moser and W.Waldhäusl: Rapid impairment of skeletal muscle glucose transport/phosphorylation by free fatty acids in man. Diabetes 48: 358-364 (1999).
  • (513) Fürnsinn, C., B.Brunmair, S.Neschen, R.Furtmüller, M.Roden, P.Nowotny, B.Schneider and W.Waldhäusl: Chronic and acute effects of thiazolidinedions BM13.1258 and BM15.2054 on rat skeletal muscle glucose metabolism. Brit.J.Pharmacol. 128: 1141 – 1148 (1999).
  • (521) Roden, M., H.Stingl, V.Chandramouli, W.C.Schumann, A.Hofer, B.R.Landau, P.Nowotny, W.Waldhäusl and G.I.Shulman: Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in man. Diabetes 49: 701-707 (2000)
  • (526) Fürnsinn, W., B.Brunmair, S.Neschen, M.Roden and W.Waldhäusl: Troglitazone directly inhibits CO2 production from glucose and palmitate in isolated rat skeletal muscle. J.Pharmacol.Exper.Ther. 293: 487-493 (2000).
  • (536) Roden, M., C.Ludwig, P.Nowotny, B.Schneider, M.Clodi, H.Vierhapper, A.Roden and W.Waldhäusl: Relative hypoleptinemia in patients with type I and type II diabetes mellitus. Int.J. Obesity 24: 976 – 981 (2000).
  • (539) W a l d h ä u s l, W. and M.Roden: Effects of free fatty acids on glucose transport/phosphorylation in skeletal muscle in humans. Current opinion in Endocrinology and Diabetes 7: 211-216 (2000).
  • (547) Kautzky-Willer,A., R.Prager, P.Nowotny, B.Ludvik, G.Pacini, B.Schneider and W.Waldhäusl: Elevated plasma leptin in gestational diabetes. Diabetologia 44: 164-172 (2001).
  • (548) Stulnig, T.M., J.Huber, N.Leitinger, E.M.Imre, P.Angelisová, P.Nowotny and W.Waldhäusl: Polyunsaturated Eicosapentaenoic acid displaces proteins from membrane rafts by alering raft lipid composition. J.Biol.Chem. 276: 37335-37350 (2001).
  • (558) Brunmair, B., F.Gras, S.Neschen, M.Roden, W.Waldhäusl and C.Fürnsinn: Direct thiazolidinedione action on rat skeletal muscle is independent of PPAR mediated changes in gene expression. Diabetes 50: 2309-2315 (2001).
  • (571) Anderwald, Ch., E.Bernroider, M.Krššák, H.Stingl, A.Brehm, M.G.Bischof, M.Roden and W.Waldhäusl: Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscles. Diabetes 51: 3025-3032 (2002).
  • (572) Fürnsinn, C., and W.Waldhäusl: Thiazolidinediones: metabolic actions invitro. Diabetologia 45: 1211-1223 (2002).
  • (589) Vierhapper, H., P.Nowotny and W.Waldhäusl: Reduced production rates of testosterone and dihydrotestosterone in healthy men treated with rosiglitazone. Metabolism 52: 230-232 (2003).
  • (600) Brunmair, B., K.Staniek, F.Gras, N.Scharf, A.Althaym, R.Clara, M.Roden, E.Gnaiger, H.Nohl, W.Waldhäusl and C.Fürnsinn: Thiazolidinediones, like Metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes 53: 1052-1059 (2004).
  • (630) W a l d h ä u s l, W.: Polypills for Treatment of Type 2 Diabetes. Is the Concept of Polypharmacy correct? In: Derek LeRoith and Aaron I. Vinik (Eds.) Controversies in Treating Diabetes. Clinical and Research Aspects.Humana Press 2008. pp. 317 – 330.
  • (641) W a l d h ä u s l, W.: Die ganzheitliche Sicht des Menschen vs. Spezialisierung in der modernen Medizin..Imago hominis 18: 277 - 285 (2011).

webdesign copyright

WebDesign © 


Ihr E-Mail